Genmab Grants Stock Units and Warrants to Employees
What happened
Genmab's Board of Directors granted 13,794 restricted stock units and 13,331 warrants to employees and subsidiaries on September 1, 2026. The restricted stock units are conditional rights to receive shares, while the warrants entitle owners to subscribe to shares upon paying an exercise price of DKK 2,268.
From manilatimes.net
Why it matters
The grant impacts Genmab's equity base and future capital structure. The restricted stock units are valued at DKK 2,268 per share, and the warrants have a calculated fair value of DKK 781.96 per warrant.
From manilatimes.net
Who's involved
- GenmabDanish biotechnology company that granted the stock units and warrants
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- GenmabSpeculative
The grant of restricted stock units and warrants could impact the company's equity base and future capital structure.
Keep exploring
The entities involved
-
Genmab
Danish healthcare company
Nothing else this week.
-
Denmark
country in Northern Europe and North America